Clinical Trial Update: Docetaxel and Capecitabine in Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of docetaxel and capecitabine in advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Stomach Neoplasm, Neoplasm Metastasis | Phase 2 | Status: COMPLETED